Inicio » Publicaciones
Publicaciones relacionadas con el BNADN
Resultados
PÉREZ-PONS A, HENRIQUES A, SANFELICIANO TC, et al. Altered B-cell, plasma cell and antibody immune profiles in blood of systemic mastocytosis. J Allergy Clin Immunol. 2024 Oct 16:S0091-6749(24)01062-5. doi: 10.1016/j.jaci.2024.10.005.
HAZELWOOD E, LOPEZ MANZANO C, VINCENT EE, et al. Plasma ghrelin and risks of sex-specific, site-specific, and early-onset colorectal cancer: A Mendelian randomization analysis. Cancer Epidemiol Biomarkers Prev. 2024 Oct 3. doi: 10.1158/1055-9965.EPI-24-0926.
CERVÁN-MARTÍN M, HIGUERAS-SERRANO I, GONZÁLEZ-MUÑOZ S, et al. Comprehensive Evaluation of the Genetic Basis of Keratoconus: New Perspectives for Clinical Translation. Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):32. doi: 10.1167/iovs.65.12.32.
TRINCADO AVE M, BRION M, BLANCO-VEREA A, et al. Prevalence and relevance of H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study. Heart. 2024 Nov 1:heartjnl-2024-324506. doi: 10.1136/heartjnl-2024-324506.
GONZÁLEZ-RODRÍGUEZ L, GONZÁLEZ LM, GARCÍA-HERRÁIZ A, et al. Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders. J Clin Med. 2024 Sep 1;13(17):5189. doi: 10.3390/jcm13175189.
SUAREZ-PAJES E, MARCELINO-RODRIGUEZ I, HERNÁNDEZ BRITO E, et al. A genome-wide association study of adults with community-acquired pneumonia. Respir Res. 2024 Oct 16;25(1):374. doi: 10.1186/s12931-024-03009-4.
GARRIDO RUIZ PA, RODRIGUEZ ÁO, CORCHETE LA, et al. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome. Biology (Basel). 2024 May 16;13(5):350. doi: 10.3390/biology13050350
VEGA-ALONSO T, LOZANO-ALONSO J, ESTÉVEZ-IGLESIAS L, et al. Health and wellbeing status of the long-lived individuals of the Spanish LONGECYL cross-sectional study. Arch Public Health. 2024 May 20;82(1):77. doi: 10.1186/s13690-024-01305-5
BULL C, HAZELWOOD E, BELL JA, et al. Identifying metabolic features of colorectal cancer liability using Mendelian randomization. Elife. 2023 Dec 21;12:RP87894. doi: 10.7554/eLife.87894
GONZÁLEZ-GIL C, MORGADES M, LOPES T, et al. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials. Haematologica. 2023 Apr 1;108(4):969-980. doi: 10.3324/haematol.2022.281196.
GARCÍA-ALBERCA JM, DE ROJAS I, SANCHEZ-MEJIAS E, et al. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response. J Alzheimers Dis. 2024;98(2):601-618. doi: 10.3233/JAD-231150.
PULITO-CUETO V, SEBASTIÁN MORA-GIL M, FERRER-PARGADA D, et al. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19. Int J Mol Sci. 2024 Mar 27;25(7):3731. doi: 10.3390/ijms25073731.
SÁEZ ME, GARCÍA-SÁNCHEZ A, DE ROJAS I, et al. Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort. Alzheimers Res Ther. 2024 Feb 16;16(1):38. doi: 10.1186/s13195-024-01398-8.
CERVÁN-MARTÍN M, GONZÁLEZ-MUÑOZ S, GUZMÁN-JIMÉNEZ A, et al. Changes in environmental exposures over decades may influence the genetic architecture of severe spermatogenic failure. Hum Reprod. 2024 Feb 1:deae007. doi: 10.1093/humrep/deae007
WANG L, NYKÄNEN NP, WESTERN D, et al. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease. Mol Neurodegener. 2024 Jan 3;19(1):1. doi: 10.1186/s13024-023-00687-4
NIMPTSCH K, ALEKSANDROVA K, PHAM TT, et al. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer. BMC Med. 2023 Oct 13;21(1):391. doi: 10.1186/s12916-023-03104-1
GONZÁLEZ-DE-OLANO D, NAVARRO-NAVARRO P, MUÑOZ-GONZÁLEZ JI, et al. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals. Allergy. 2023 Oct 11. doi: 10.1111/all.15911
OLIVA-ARIZA G, FUENTES-HERRERO B, LECREVISSE Q, et al; ECRIN-M3 Consortium. Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis. Am J Hematol. 2023 Oct 4. doi: 10.1002/ajh.27119
ONIEVA A, MARTIN J, CUESTA-AGUIRRE DR, et al. Complete mitochondrial DNA profile in stroke: a geographical matched case-control study in Spanish population. Mitochondrion. 2023 Oct 2:S1567-7249(23)00084-3. doi: 10.1016/j.mito.2023.10.001
GONZÁLEZ-MUÑOZ T, DI GIANNATALE A, GARCÍA-SILVA S, et al. Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Clin Cancer Res. 2023 Sep 15;29(18):3744-3758. doi: 10.1158/1078-0432.CCR-22-2462
BATISTA-LIZ JC, CALVO-RÍO V, SEBASTIÁN MORA-GIL M, et al. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis? Int J Mol Sci. 2023 Aug 22;24(17):13063. doi: 10.3390/ijms241713063.
CASTRO-SANTOS P, ROJAS-MARTINEZ A, RIANCHO JA, et al; Scourge Cohort Group
MAHMOOD K, THOMAS M, QU C; GECCO-CCFR CONSORTIUM; HSU L, BUCHANAN DD, PETERS U. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes. Gastroenterology. 2023 Jul 14:S0016-5085(23)04770-4. doi: 10.1053/j.gastro.2023.06.032
ALEMANY-NAVARRO M, DIZ-DE ALMEIDA S, CRUZ R, et al. Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19. Transl Psychiatry. 2023 Jun 6;13(1):189. doi: 10.1038/s41398-023-02482-7
PAIRO-CASTINEIRA E, RAWLIK K, BRETHERICK AD, et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature. 2023 May;617(7962):764-768. doi: 10.1038/s41586-023-06034-3
noticias
ADN AL DÍA
FORMACIÓN Y PROYECTOS
CONGRESOS Y REUNIONES
Banco Nacional de ADN
Edificio Multiusos I+D+i (Universidad de Salamanca)
C/ Espejo s/n. 37007 Salamanca
Teléfono de contacto: 923294500. Ext. 5473
Edificio Multiusos I+D+i (Universidad de Salamanca)
C/ Espejo s/n. 37007 Salamanca
Teléfono de contacto: 923294500. Ext. 5473
